-
Sep 24, 2024 | 
theoncologypharmacist.com | William King |Juliette Cubanski |Tricia Neuman |Charlie Dawson
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
Sep 6, 2024 | 
theoncologypharmacist.com | Meg Barbor |Charlie Dawson |Chase Doyle
"Encourage Your Patients to Participate! US-Based Clinical Trials That Are Actively Recruiting in Ovarian Cancer" was originally published by Oncology Practice Management.
Clinical trial recruitment and retention remain challenges in the quest to bring innovative therapies to all patients in need. In oncology, therapies continue to evolve, yet researchers are frequently faced with low trial participation, particularly among minority groups.
-
Jul 24, 2024 | 
oncpracticemanagement.com | Charlie Dawson
The variety of ongoing research in cancer has never been more dynamic. Increased understanding into the pathogenesis of cancers, intriguing research into the development of new treatments, the establishment of advanced methods of identifying actionable targets for treatment, and improved strategies for managing adverse events occurring with therapy are among the up-to-the-minute topics in the field.
-
Jun 27, 2024 | 
theoncologypharmacist.com | Dawn Holcombe |Charlie Dawson |Anne Rowe |Gail Thompson
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
Jun 27, 2024 | 
theoncologypharmacist.com | Meg Barbor |Charlie Dawson |Chase Doyle
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
Jun 27, 2024 | 
theoncologypharmacist.com | Meg Barbor |Charlie Dawson |Chase Doyle
Clinical trial recruitment and retention remain challenges in the quest to bring innovative therapies to all patients in need. In oncology, therapies continue to evolve, yet researchers are frequently faced with low trial participation, particularly among minority groups.
-
Jun 26, 2024 | 
theoncologypharmacist.com | Meg Barbor |Charlie Dawson |Colleen Hall
BOSTON—Imagine a circle, with healthcare providers, researchers, and community partners such as churches making up the outer ring. In the center, picture a patient with cancer. All of those groups working together is the key to boosting clinical trial engagement, particularly in underrepresented populations, according to a panel of speakers at NCODA’s 6th Annual Oncology Institute meeting held in Boston in August.
-
May 28, 2024 | 
theoncologypharmacist.com | William King |Patricia Stewart |Charlie Dawson |Wayne Kuznar
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
May 28, 2024 | 
theoncologypharmacist.com | Patricia Stewart |Charlie Dawson |William King |Phoebe Starr
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
Mar 18, 2024 | 
theoncologypharmacist.com | William King |Patricia Stewart |Charlie Dawson
Colorectal cancer (CRC) is the second most common cause of cancer-related death in the United States and is the leading cause of death in men aged <50 years.1 In recent years, the diagnosis of CRC has been shifting to a younger age and a more advanced stage.1,2 In fact, 1 in 5 new cases of CRC occurs in people aged <50, and more individuals are diagnosed at an advanced stage now than in the mid-1990s before widespread screening.1 Consensus is lacking as to why colorectal cancer is rising in...
